Task Force Issues Draft Recommendation : Advices Against Asp
US Preventive Services Task Force (USPSTF) has released new recommendation protocol on the use of aspirin for the primary prevention of cardiovascular disease (CVD) and appears to limit the population in which it should be considered. The USPSTF has changed the age ranges and grades of its recommendation on aspirin use. It recommends that the decision to initiate low-dose aspirin use for the primary prevention of CVD in adults ages 40 to 59 years who have a 10% or greater 10-year CVD risk should be an individual one, and it also recommends against initiating low-dose aspirin use for the primary prevention of CVD in adults age 60 years or older. Based on new analyses of the evidence from primary CVD prevention populations, longer-term follow up data from the Women’s Health Study and new trial evidence, the USPSTF concluded that the evidence is inadequate that low-dose aspirin use reduces CRC incidence or mortality.

Source: https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
Like
Comment
Share